US Patent Issued to The Jackson Laboratory, Henry Ford Health System on Feb. 24 for "Method of targeting patient-specific oncogenes in extrachromosomal DNA to treat glioblastoma" (Connecticut, Michigan Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,789, issued on Feb. 24, was assigned to The Jackson Laboratory (Bar Harbor, Maine) and Henry Ford Health System (Detroit).

"Method of targeting patient-specific oncogenes in extrachromosomal DNA to treat glioblastoma" was invented by Roel Verhaak (West Hartford, Conn.), Hoon Kim (West Hartford, Conn.), Ana Decarvalho (Detroit) and Tom Mikkelsen (Detroit).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods of targeting patient-specific oncogenes in extrachromosomal DNA (ecDNA) to treat glioma in a human. The present methods include identifying a drug that targets against an oncogene present in ecDNA of a human suffering from glioma, su...